Kevin美股成长价投2019-12-31 06:31
$Orgenesis(ORGS)$ $BioLife Solutions(BLFS)$ 近几年美国细胞治疗和再生医学领域发展迅速,投入资本年增长速度超过20%,Orgs为其它公司提供研发服务。算是这波细胞治疗和再生医学淘金热潮里卖铲子的商家。所以近几年公司录的非常稳定而高速的营收增长。股价从高位大幅调整下来,已经开始修复,目...查看全文
牛唐2019-10-11 22:12
$BioLife Solutions(BLFS)$ 全部收购了SAVSU,受益于细胞疗法的火热,2019年收入指引是增长39%,毛利率是七成左右,目前股价回调的厉害,可以关注查看全文
$BioLife Solutions(BLFS)$ 8-K Current report, item 5.02 Accession Number: 0001437749-21-022330 Act: 34 Size: 153 KB 网页链接
$BioLife Solutions(BLFS)$ 内部交易: 2021-09-09,CEO,Rice Michael ,卖出,11461普通股, $52.59
$BioLife Solutions(BLFS)$ 内部交易: 2021-09-07,CEO,Rice Michael ,卖出,11461普通股, $52.50
$BioLife Solutions(BLFS)$ 内部交易: 2021-09-07,CEO,Rice Michael ,期权,11461普通股, $1.64
$BioLife Solutions(BLFS)$ 内部交易: 2021-09-09,CEO,Rice Michael ,期权,11461普通股, $1.64
$BioLife Solutions(BLFS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-021860 Size: 14 KB 网页链接
$BioLife Solutions(BLFS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-21-008973 Act: 34 Size: 13 KB 网页链接
$BioLife Solutions(BLFS)$ 8-K Current report, item 2.01 Accession Number: 0001437749-21-021587 Act: 34 Size: 153 KB 网页链接
$BioLife Solutions(BLFS)$ S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers Accession Number: 0001437749-21-021321 Act: 33 Size: 900 KB 网页链接
$BioLife Solutions(BLFS)$ 内部交易: 2021-08-26,CEO,Rice Michael ,卖出,848普通股, $57.26